Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

PharmAust Progresses to Elevated Doses in MND Patients

PharmAust Progresses to Elevated Doses of MPL in MND Patients

Category: News and Announcements 2023By PharmAust January 20, 2023

Related posts

Notice of General Meeting
May 26, 2023

Motor Neurone Disease Clinical Trial Update
May 22, 2023

Progress update on Phase 1/2 MND interim analysis
May 16, 2023

Independent tests show MPL retains long-term shelf-life
May 10, 2023

MPL has anti-cancer effects across multiple cancer types
May 9, 2023

PharmAust Raises $2.5m via Placement
May 3, 2023

Recent Articles

Notice of General Meeting
May 26, 2023
Motor Neurone Disease Clinical Trial Update
May 22, 2023
Progress update on Phase 1/2 MND interim analysis
May 16, 2023
Independent tests show MPL retains long-term shelf-life
May 10, 2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

pharmaust Follow

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions